A review of whole brain radiotherapy outcomes in a high epidermal growth factor receptor mutation rate population: Does QUARTZ apply in Asia?
Ivy Wei Shan NgJeremy Chee Seong TeyDavid Wei Tsau ChiaChoon Meng YeeTimothy Song Tao CheoPublished in: Asia-Pacific journal of clinical oncology (2019)
Our patients appear to be considerably different from those recruited into the QUARTZ trial. Further prospective studies should be done to evaluate the value of WBRT in our population.
Keyphrases
- epidermal growth factor receptor
- end stage renal disease
- tyrosine kinase
- ejection fraction
- advanced non small cell lung cancer
- newly diagnosed
- clinical trial
- radiation therapy
- prognostic factors
- squamous cell carcinoma
- study protocol
- randomized controlled trial
- small cell lung cancer
- type diabetes
- metabolic syndrome
- white matter
- brain injury
- patient reported outcomes
- adipose tissue
- open label
- patient reported